Component resolved-diagnosis: low cost, high efficiency
Over 150 million people in Europe suffer from some type of allergy. Like other autoimmune diseases, allergies have to be treated as soon as possible to prevent associated degeneration damage. An effective diagnosis is necessary to reduce treatment cost and to improve the quality of patient. Over 30 million of diagnostic tests will be conducted the next year. So far, allergies have been diagnosed by using mixtures of allergens, making it difficult to determine which allergen is responsible for a particular allergy and find the right treatment. Componen resolved diagnosis means to use purified allergens as alternative test. This method provides an advantage over classic ways because it reduces the spending per patient (average savings of 6 euros) but also, it increases the efficiency of diagnosis (20-40%) what implies an improvement in the treatment and the quality of life of patients.
Detectallergen is specialized in the isolation of allergens to use in Component Resolved Diagnosis for allergies. Our products are manufactured under the strict GMP rules (GMP), with the highest standards of quality. That means that our products can be employed for diagnostic platforms and skin-prick test.
The use of purified allergens from known sources allows to diagnose allergy with high efficiency.
"A good diagnosis reduces the spending on allergy treatment up to 30% per person and year"
"During 2015, a million people will be conducted an allergy test in Spain, with an average expenditure of 10-14 euros per person"
Araceli Díaz Perales
Centre for Plant Biotechnology and Genomics (CBGP-UPM)
Innovation, Commercialization and Entrepreneurship Area
Centre of Support for Technological Innovation - UPM